Skip to content

Sexual Health and Breast Cancer: Developing Appropriate Education for Women Going Through Treatment

Sexual Health and Breast Cancer: Developing Appropriate Education for Women Going Through Treatment

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06121258
Enrollment
32
Registered
2023-11-07
Start date
2024-01-02
Completion date
2025-01-22
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Female, Sexual Dysfunction

Keywords

Breast cancer, sexual health, educational video

Brief summary

The purpose of this study is to assess the acceptability, appropriateness, and feasibility of a educational video series for patients going through breast cancer treatment.

Detailed description

This is a prospective, mixed methods pilot study to evaluate the acceptability, appropriateness, and feasibility of a novel educational video series for patients going through breast cancer treatment. The video series addresses topics such as what to expect from breast surgery, how to prepare for breast surgery, treatment effects of breast cancer therapies, and mitigation and communication strategies for navigating breast cancer treatment.

Interventions

OTHEREducational video series

The intervention is a web-based educational video series that was developed using a patient-centered approach that discusses breast cancer treatment, sexual health side effects, and provides treatment and mitigation strategies for these side effects.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER
International Society for the Study of Women's Sexual Health
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Stage I-III invasive breast cancer within one month of initial multi-disciplinary clinic visit or surgical consultation * Ability to complete survey material independently * Able to read and speak English * Willingness to comply with study material and procedures

Exclusion criteria

* Age \< 18 years old * Stage 0 or IV breast cancer * Non-breast cancer diagnoses * History of anti-hormonal therapy, chemotherapy, or radiotherapy not related to breast cancer * Prior breast cancer diagnosis

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of the educational video series after six-months of access and use by breast cancer patients as measured by AIM instrument.6 monthsThe Acceptability of Intervention Measure (AIM) is a validated instrument used to measure the acceptability of an intervention. Scores range from 0-5. There is no score cut off, however higher scores indicate better outcomes (greater acceptability).
Appropriateness of the educational video series after six-months of access and use by breast cancer patients as measured by IAM instrument.6 monthsThe Intervention Appropriateness Measure (IAM) is a validated instrument used to measure the appropriateness of an intervention. Scores range from 0-5. There is no score cut off, however higher scores indicate better outcomes (greater appropriateness).
Determine the sustainability of the educational video series after six-months of access and use by breast cancer patients as measured by the FIM instrument.6 monthsThe Feasibility of Intervention Measure (FIM) is a validated instrument used to measure the feasibility, or sustainability, of an intervention. Scores range from 0-5. There is no score cut off, however higher scores indicate better outcomes (greater feasibility).

Secondary

MeasureTime frameDescription
Change from baseline in sexual health and function at six-months, as measured by the PROMIS Sexual Function v2 Brief Profile (Female)Baseline, 6 monthsThe Patient-Reported Outcomes Measurement Information System (PROMIS) Sexual Function v2 Brief Profile (Female) is a well-validated tool in oncology patients to assess sexual health. Calibrated subdomain scores are expressed as T-scores (mean=50, standard deviation=10). A T-score 50 corresponds to the mean response among cancer survivors used for previous item testing. Higher scores indicate better outcomes within the domain. We will assess the change at 6 months from baseline.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSarah E Tevis, MD

University of Colorado, Denver

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026